Table 1. Sociodemographic and clinical characteristics of newborns undergoing percutaneous catheterization, Curitiba, Paraná, Brazil, 2023.
Variable | Control Group (n=56) |
Experimental Group (n=55) |
p * | ||
---|---|---|---|---|---|
n (%) | Median (95%CI) |
n (%) | Median (95%CI) |
||
Gestational age at birth (weeks) | 36 (34-38) | 36 (33-38) | 0.785 1 | ||
Age at insertion (days) | 36 (23-43) | 29 (11-59) | 0.797 1 | ||
Birth weight (grams) | 2268 (1650-2780) | 2355 (1420-2755) | 0.969 1 | ||
SNAPPE II scale ** | 8 (5-15) | 5 (5-15) | 0.255 1 | ||
DIVA score *** ≥ 4 | 34 (48.6) | 36 (51.4) | 0.605 2 | ||
Catheter indication | 0.773 2 | ||||
Therapy incompatible with peripheral route | 48 (49.0) | 50 (51.0) | |||
Therapy ≥ 7 days | 10 (47.6) | 11 (52.4) | |||
Difficult venous access | 37 (48.7) | 39 (51.3) | |||
Diagnosis that culminated in catheter insertion | 0.497 2 | ||||
Infectious and parasitic diseases | 16 (48.5) | 17 (51.5) | |||
Disorders of other endocrine glands | 1 (100.0) | 0 (0.0) | |||
Diseases of the nervous system | 1 (33.3) | 2 (66.7) | |||
Diseases of the respiratory system | 5 (50.0) | 5 (50.0) | |||
Diseases of the digestive system | 3 (37.5) | 5 (62.5) | |||
Diseases of the genitourinary system | 2 (66.7) | 1 (33.3) | |||
Conditions originating in the neonatal period | 24 (60.0) | 16 (40.0) | |||
Congenital malformations, deformities and chromosomal anomalies | 4 (28.6) | 10 (71.4) |
n - numberof participants;
p - <0.05,
SNAPPE - Score for Neonatal Acute Physiology Perinatal Extension,
DIVA - Difficult Intravenous Access; p value -
Kruskal-Wallis,
Pearson’schi-square.